Characterization of Apolipoprotein C3 (Apo C3) LNA/DNA Impurities and Degradation Products by LC-MS/MS

Olga V Friese1, Justin B Sperry2, Yan He2

  • 1Biotherapeutics Pharmaceutical Sciences, Pfizer WRD, St. Louis, Missouri, USA. olga.v.friese@pfizer.com.

The AAPS Journal
|May 11, 2017
PubMed

Related Concept Videos